Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients

Go back to Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients

Cigna Corp. (CI) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Guidance Below Consensus

February 1, 2019 6:03 AM EST

(Updated - February 1, 2019 6:03 AM EST)

Cigna Corp. (NYSE: CI) reported Q4 EPS of $2.46, $0.09 better than the analyst estimate of $2.37. Revenue for the quarter came in at $13.75 billion versus the consensus estimate of $11.71 billion.

Cigna completed an exceptionally strong 2018, with revenue, customer, and earnings... More